T S Dietlein1, J Jordan, C Lueke, G K Krieglstein. 1. Department of Ophthalmology, University of Cologne, Joseph-Stelzmann-Str. 9, D-50931, Köln, Germany. Thomas.Dietlein@uk-koeln.de
Abstract
BACKGROUND: Antiglaucomatous implant surgery is a continously evolving field in glaucoma treatment. METHODS: A literature search with the terms "glaucoma implant surgery", "aqueous shunts" and "glaucoma drainage devices" was carried out, especially giving prominence to innovative surgical developments in glaucoma implant surgery and to recently established clinical evidence on traditional shunt surgery. RESULTS: Episcleral glaucoma drainage devices have recently proven their efficacy in large studies. Longterm data about their clinical efficacy and their risk/safety profile are sufficiently available. New antiglaucomatous devices try to target alternative drainage routes, for example trabecular or uveoscleral outflow. Valid longterm data from prospective randomized clinical trials are not available for these devices as yet. CONCLUSIONS: Although valid data on clinical application of the new glaucoma implants are not available as yet, profound knowledge about their theoretical concept and their practical management is obligatory for all glaucoma clinicians.
BACKGROUND: Antiglaucomatous implant surgery is a continously evolving field in glaucoma treatment. METHODS: A literature search with the terms "glaucoma implant surgery", "aqueous shunts" and "glaucoma drainage devices" was carried out, especially giving prominence to innovative surgical developments in glaucoma implant surgery and to recently established clinical evidence on traditional shunt surgery. RESULTS:Episcleral glaucoma drainage devices have recently proven their efficacy in large studies. Longterm data about their clinical efficacy and their risk/safety profile are sufficiently available. New antiglaucomatous devices try to target alternative drainage routes, for example trabecular or uveoscleral outflow. Valid longterm data from prospective randomized clinical trials are not available for these devices as yet. CONCLUSIONS: Although valid data on clinical application of the new glaucoma implants are not available as yet, profound knowledge about their theoretical concept and their practical management is obligatory for all glaucoma clinicians.
Authors: S Roters; C Lüke; C P Jonescu-Cuypers; B F Engels; P C Jacobi; W Konen; G K Krieglstein Journal: Br J Ophthalmol Date: 2002-09 Impact factor: 4.638
Authors: Darrell WuDunn; Anh-Danh T Phan; Louis B Cantor; John T Lind; Arnold Cortes; Bin Wu Journal: Ophthalmology Date: 2006-05 Impact factor: 12.079
Authors: R Allemann; O Stachs; K Falke; W Schmidt; S Siewert; K Sternberg; B Chichkov; A Wree; K-P Schmitz; R F Guthoff Journal: Ophthalmologe Date: 2013-08 Impact factor: 1.059
Authors: R F Guthoff; W Schmidt; D Buss; C Schultze; U Ruppin; O Stachs; K Sternberg; D Klee; B Chichkov; K-P Schmitz Journal: Ophthalmologe Date: 2009-09 Impact factor: 1.059
Authors: Robert Siggel; Falk Schroedl; Thomas Dietlein; Konrad R Koch; Christian Platzl; Alexandra Kaser-Eichberger; Claus Cursiefen; Ludwig M Heindl Journal: Histol Histopathol Date: 2020-12-31 Impact factor: 2.303
Authors: Marina Hovakimyan; Stefan Siewert; Wolfram Schmidt; Katrin Sternberg; Thomas Reske; Oliver Stachs; Rudolf Guthoff; Andreas Wree; Martin Witt; Klaus-Peter Schmitz; Reto Allemann Journal: Transl Vis Sci Technol Date: 2015-06-30 Impact factor: 3.283
Authors: Marian Löbler; Diana Buß; Christian Kastner; Jörg Mostertz; Georg Homuth; Mathias Ernst; Rudolf Guthoff; Andreas Wree; Thomas Stahnke; Georg Fuellen; Uwe Voelker; Klaus-Peter Schmitz Journal: Mol Vis Date: 2013-06-12 Impact factor: 2.367